Title |
RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies
|
---|---|
Published in |
Molecular BioSystems, January 2015
|
DOI | 10.1039/c5mb00278h |
Pubmed ID | |
Authors |
Meenakshi Malhotra, André Toulouse, Bruno M. D. C. Godinho, David John Mc Carthy, John F. Cryan, Caitriona M. O'Driscoll |
Abstract |
Malignant primary brain tumors are aggressive cancerous cells that invade the surrounding tissues of the central nervous system. The current treatment options for malignant brain tumors are limited due to the inability to cross the blood-brain barrier. The advancements in current research has identified and characterized certain molecular markers that are essential for tumor survival, progression, metastasis and angiogenesis. These molecular markers have served as therapeutic targets for the RNAi based therapies, which enable site-specific silencing of the gene responsible for tumor proliferation. However, to bring about therapeutic success, an efficient delivery carrier that can cross the blood-brain barrier and reach the targeted site is essential. The current review focuses on the potential of targeted, non-viral and viral particles containing RNAi therapeutic molecules as delivery strategies specifically for brain tumors. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 4 | 31% |
United Kingdom | 2 | 15% |
Australia | 1 | 8% |
Thailand | 1 | 8% |
United States | 1 | 8% |
France | 1 | 8% |
Unknown | 3 | 23% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 62% |
Scientists | 3 | 23% |
Science communicators (journalists, bloggers, editors) | 1 | 8% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Unknown | 53 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 22% |
Student > Master | 12 | 22% |
Student > Bachelor | 7 | 13% |
Researcher | 7 | 13% |
Student > Doctoral Student | 3 | 6% |
Other | 6 | 11% |
Unknown | 7 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 15% |
Agricultural and Biological Sciences | 8 | 15% |
Engineering | 6 | 11% |
Chemistry | 5 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
Other | 12 | 22% |
Unknown | 11 | 20% |